Clinical Trial Update: HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program

View source ↗

Summary

This clinical trial update notes the completion of a neoadjuvant coordination of care program for HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Duke University | Conditions: Breast Cancer | Status: COMPLETED